In short
A personalised longevity plan is not a longer list of tests. It is a shorter one, chosen because your risk band and your risk enhancers make those specific tests worth doing.
Four things personalise it.
- Your risk band, which determines whether medication is warranted at all
- Your risk enhancers, the factors your calculator leaves out
- Your age, which sets both the screening list and the review interval
- What you will actually do, since a plan you do not follow has no effect size
Treatment Overview
What actually makes a plan personal?
Not a longer panel. The four inputs that change the plan are your calculated risk band, the enhancers your calculator omits, your age, and what you will realistically sustain.
Which calculator is used changes the number, and no single model fits every patient. Why the choice of calculator matters.
How the risk band decides the plan
Your calculated 10 year risk of a heart attack or stroke falls into one of four bands, and each band has a defined answer. The table gives the answer attached to each band and what would change it.
| 10 year risk | What follows |
|---|---|
| Under 3 percent (low) | Lifestyle. Most people gain nothing from medication. Reassess in four to six years. A calcium score is not recommended, because it rarely reclassifies anyone in this band. |
| 3 to under 5 percent (borderline) | The genuinely uncertain group. Risk enhancers and 30 year risk are weighed, and a coronary calcium score frequently settles it. |
| 5 to under 10 percent (intermediate) | A statin is usually suggested, more strongly at the top of the range. A calcium score is reasonable if you would rather avoid medication. |
| 10 percent or more (high) | Treat. No further stratification is needed. |
These thresholds belong to the PREVENT calculator. A different calculator comes with different thresholds, which is why the cut off cannot be borrowed from one model and applied to another. How much the calculator changes the number.
Why is the same test right for one person and wrong for another?
Take a coronary calcium score, a short CT scan that measures calcified plaque in the heart arteries. At low risk it is not recommended, because it is unlikely to move you into a different category. At borderline risk it often changes the decision in either direction.
If your LDL cholesterol is already 190 mg/dL or above, a calcium score is generally not done at all, because treatment is indicated regardless of the result.
The radiation dose is small. A calcium scan is performed at no more than 1 mSv, which is comparable to a screening mammogram at about 0.8 mSv, and modern scanners manage it below 0.4 mSv.
At what age is a first calcium score worth considering?
Earlier when you have diabetes. In a consortium study of more than 22,000 people, the age at which a first scan was most likely to be informative was 35 to 38 for men with diabetes and 41 to 44 for men without, and 49 to 52 versus 56 to 60 for women.
Diabetes was associated with developing coronary calcium about 6.4 years earlier than in people with no risk factors, while smoking, high blood pressure, abnormal lipids and a family history each moved it forward by 3.3 to 4.3 years.
What are risk enhancers and why do they matter here?
Risk enhancers are factors that raise your real risk but sit outside some calculators. They do not change the number, they change how the number is read, and they are decisive precisely at borderline and intermediate risk.
In diabetes the recognised ones are a duration of 10 years or more for type 2 and 20 years for type 1, albuminuria of 30 mcg/mg creatinine or more, kidney function below 60 mL/min/1.73, retinopathy and neuropathy.
A well documented family history of early heart disease is used the same way. It is not in every calculator and does not always improve a model statistically, but it belongs in the conversation.
Why does age shape the plan more than anything else?
- 20 to 29: risk factors are identified and discussed, but calculators are not routinely used, because absolute risk is very low and the estimate is unreliable
- 30 to 79: quantitative risk calculation, with a 30 year estimate added between 30 and 59 when the 10 year figure is low or borderline
- Over 79: individualised. Age dominates the calculation, so most people land at intermediate risk regardless, and calculators may overestimate
Risks are explained in absolute terms rather than as a percentage reduction. Why absolute numbers are used.
Personalised longevity plans in Dubai and the UAE
Does the age framework above fit patients in Dubai?
Not always, and that is the main local adjustment. In a Dubai cath lab series of 110 patients with premature coronary artery disease, the average age was 42.0 years in men and 48.8 in women (Cureus, 2025).
In that group 83.6 percent had abnormal lipids, 86.3 percent were overweight or obese and 33.6 percent had diabetes. A plan built on the assumption that risk starts at 50 misses that population.
What does the local diabetes picture change?
It moves the calcium score question forward. Diabetes brings the informative age for a first scan forward by several years, and diabetes is common here: the national survey of the Ministry of Health and Prevention found raised blood glucose in 12.5 percent of adults.
Among the Dubai patients with early coronary disease, 63.6 percent were of Asian background, and diabetes was far more common in that group than in the others (45.7 percent versus 12.5 percent). Why the population a calculator was built on matters here.
Where do the reviews happen?
At Dubai Healthcare City. Follow-up can be arranged through individual consultations or a Longevity Membership. The review interval is based on your risk and agreed care plan. The review intervals.
Who Is a Good Candidate?
- You have results but no plan, or a plan nobody explained
- Your calculated risk came out borderline and you were left to decide alone
- You have diabetes, kidney disease or an autoimmune condition that standard calculators handle poorly
- You would rather avoid daily medication and want to know whether that is reasonable for you
- You want the plan to fit the life you actually have
- Established cardiovascular disease, where the plan is secondary prevention rather than risk estimation
- LDL cholesterol of 190 mg/dL or above, which needs treating and assessment for an inherited cause
- An active symptom, which needs a diagnosis before a prevention plan
What Happens During the Consultation
-
1
Where you actually are
Calculated 10 year risk, plus 30 year risk between 30 and 59 where the 10 year figure is low or borderline. A low 10 year risk with a lifetime risk of 10 per cent or more changes the conversation.
-
2
What the calculator missed
Risk enhancers, family history with ages attached, and in diabetes the duration, albuminuria, kidney function, retinopathy and neuropathy. These adjust the reading rather than the number.
-
3
Only the tests that would change something
A calcium score where the decision is genuinely uncertain. No score at low risk, and none when LDL is already 190 or above, because treatment is indicated either way.
-
4
A plan you have agreed to
Named medication or no medication, named targets, two or three behaviour changes with numbers, and a review interval. Your own threshold for taking medication is part of the decision.
Program Structure & Follow-Up
How the plan runs over time
The interval follows the risk band, and a material change brings the review forward.
| Situation | Interval |
|---|---|
| Low risk | Reassess in four to six years, sooner if a risk factor changes, such as new high blood pressure |
| Borderline | Yearly reassessment is reasonable |
| Intermediate | Yearly measurement and discussion of risk reduction |
| On new medication | Sooner, for monitoring and adjustment |
What triggers an early review
- A new diagnosis: high blood pressure, diabetes, kidney disease
- A change in medication
- A new symptom, particularly on exertion
- A family diagnosis that changes your history
What is deliberately not repeated
Calcium scoring is not repeated to see whether treatment is working, because the progression adds little to what the first scan told you. If your score was zero, a repeat at three to seven years is reasonable only where it would change a decision.
When targets change
If plaque is found, the targets tighten. A calcium score of 100 to 299 brings an LDL goal under 70 mg/dL, and 300 or more a goal under 55 mg/dL, which are the targets used for people with known heart disease.
A calcium score above 300 in someone with no history of heart attack or stroke carried a risk of heart attack and death similar to that of people with established disease, in a registry analysis of cardiac CT patients.
Benefits, Limits & Safety
What does personalisation actually achieve?
Fewer people on medication who would not benefit, and fewer people missed who would. Both errors are common when a single threshold is applied to everyone.
It also changes who gets reassured. A calcium score of zero is the strongest de-risking result available, and for the right person it is a reason not to start treatment.
Where personalisation reaches its limits
- Calculators estimate the average risk of people like you, not your risk. That is a real limitation, not a technicality
- External validation is imperfect, and newer models have underestimated observed events in some health systems
- Evidence for acting on a 30 year risk figure alone is limited, and that is said when it is used
- Breast cancer risk tools are inaccurate for women with several affected first degree relatives
What does not personalise a plan
A longer test list, a biological age score or a consumer genomic panel does not automatically make care more personal or improve outcomes. A membership defines the agreed scope of ongoing care; the investigations within that care still need an individual clinical reason.
None of the treatments marketed as anti ageing has been shown to change outcomes, so none of them personalises anything either. The evidence for each of them.
What if you decline treatment?
That is a legitimate decision, provided it is informed. Where the choice is genuinely balanced you will be told that it is balanced, and the plan then focuses on what you are willing to do rather than on what you declined.
What a real plan contains
A risk band, named targets, a decision on medication either way, two or three behaviour changes with numbers, and a review date.
Intervals set by risk
Four to six years if low, yearly at borderline or above, sooner if a risk factor changes or medication is started.
What is left out
Tests that would not change anything, repeat calcium scoring to monitor treatment, biological age scores and consumer genomic panels.
Cost & Program Investment
You can start with an individual consultation or discuss ongoing care through a Longevity Membership. The proposed scope, fees and any additional investigations or medicines are explained before you agree. Your risk and clinical needs determine the plan. If a test would not change your care, that is explained rather than adding it to the programme.
Frequently Asked Questions
Your calculated risk band, the risk enhancers your calculator omits, your age, and what you will realistically sustain. Those four inputs change the plan far more than any genomic result available today.
It depends where you sit. Not at low risk, where it rarely reclassifies anyone. Often at borderline risk, where it settles the decision. Reasonable at intermediate risk if you are hesitant about medication. Generally not if your LDL cholesterol is already 190 mg/dL or above, because treatment is indicated regardless.
Earlier if you have diabetes. In a consortium study of more than 22,000 people the most informative age for a first scan was 35 to 38 for men with diabetes against 41 to 44 without, and 49 to 52 for women with diabetes against 56 to 60 without.
Not necessarily. Between 30 and 59 a 30 year estimate is added when the 10 year figure is low or borderline, because a low short term risk can sit alongside a high lifetime one.
No. Risk thresholds exist to open a discussion, not to end one. People have different thresholds for daily medication and that is a legitimate input. A coronary calcium score often makes the choice clearer in either direction.
Every four to six years if you are low risk, yearly at borderline risk or above, and sooner if a risk factor changes or you start medication.
Yes. A calcium score can change the recommended intensity of lipid treatment. The LDL goal depends on the calcium burden, overall risk and the guideline used; a score of 300 or more is not an automatic rule that every person needs LDL below 55 mg/dL. Your clinician explains the proposed target and reasons.
Yes. Bring the results, the calculator used and the recommendations. Different calculators give different answers for the same person, and that alone explains many conflicting recommendations.
Not without adjustment. In a Dubai series of 110 patients with premature coronary artery disease the average age was 42 in men, and 63.6 percent were of Asian background with a diabetes rate of 45.7 percent. Age thresholds and the choice of calculator both need checking against the person in front of you.
Evidence
Where this information comes from
Every figure on this page is taken from the sources below. All of them are free to read, so you can check them yourself.
- PREVENT online calculator for cardiovascular risk
- Major determinants of early-onset coronary artery disease: a descriptive study from a tertiary care hospital in Dubai
- MoHAP releases National Health and Nutrition Survey 2024-2025
- High prevalence of cardiometabolic risk factors amongst young adults in the United Arab Emirates: the UAE Healthy Future Study
- Coronary artery calcium score and polygenic risk score for the prediction of coronary heart disease events
- Grade definitions for preventive services
This page is general medical information and does not replace a personal consultation. Trial results are averages across large groups, not a prediction for any one person.